Health News Releases

  • Today March 14
The global pharmaceutical trade body calls on countries to enable innovation, mobilize investment, d
March 12, 17:15
Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease
Ahead of a major UN milestone (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.who.int%2Fteams%2Fnoncommunicable-diseases%2Fon-the-road-to-2025%23Shaping%2520a%2520transformative
From left: Award recipients Kazuhiko Omote, General Manager, X-ray Research Laboratory; and Raita Hi
March 12, 11:05
Rigaku Wins Diana Nyyssonen Memorial Best Paper Award with Method for Inspecting and Measuring Defects in 3D Flash Memory
Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has won the Diana Nyyssonen Memorial Best Paper Award (herei
March 11, 16:40
Kenvue Announces Three New Appointments to Board of Directors
Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero,
(Graphic: Business Wire)
March 07, 13:30
BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54216036&newsitemid=20250227911272&lan=en-US&anchor=BeiGene&index=1&md5=e2cdff0a0d83750ab7730987260
March 07, 11:45
Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its
March 06, 17:30
InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record
InterSystems (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.intersystems.com&esheet=54216543&newsitemid=20250304321284&lan=en-US&anchor=InterSystems&index=1&md5=2a1879be82b01b2
March 06, 15:45
Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency[1], and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for another consecutive year while maki
Preliminary data from Parse’s chromatin assay showing clustering of mouse brain nuclei based on DNA
March 06, 11:30
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products
Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin prod
Nurse Maria Victoria Juan from Philippines – Winner of Aster Guardians Global Nursing Award 2024 (Ph
March 06, 10:10
Aster Guardians Global Nursing Award 2025 Worth $250,000 Extends Nomination Deadline to 9th March
Aster Guardians Global Nursing Award 2025 - an initiative by the leading integrated healthcare provider, Aster DM Healthcare, has extended the deadline for submission of nominations to 9th March, 2025
March 04, 10:49
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX (https://www.protagonist-inc.com/)) and Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive top
March 03, 13:20
New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits
Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the stu
March 03, 12:00
Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
Astria Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fastriatx.com%2F&esheet=54215940&newsitemid=20250227320197&lan=en-US&anchor=Astria+Therapeutics%2C+Inc.&inde
March 03, 10:40
SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court
February 28, 16:30
Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East
Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices
February 28, 11:25
The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in
X-ray imaging results of D23 (Budesonide Ileum Targeted Tablet) (Graphic: Business Wire)
February 27, 14:00
Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results
Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-
BROADMEDI CEO Kim Sun-ae, Korea Hospital Coordinator Association President Lee Soo-jae
February 26, 16:48
BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tourism Services
BROADMEDI, a leading medical tourism platform of CREINNOS, has signed a strategic Memorandum of Understanding (MOU) with the Korea Hospital Coordinator Association (KHCA) to enhance service quality in
KEYRESEARCH’s ‘Aco-Alpha’ Sells Out in First Batch with Proprietary Technology
February 24, 16:43
KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day
KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high
Portrait: Dr. Rudolf Widmann | Member of the Board of Directors & Founder | AOP Health | Photocredit
February 23, 13:20
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti
PelviTouch Therapy Presentation at ESSM Congress (Photo by DEKA)
February 23, 11:50
Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology
DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec
February 23, 11:15
CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt
Ferrer team celebrating becoming the pharmaceutical company with the highest B Corp score (Photo: Bu
February 21, 10:40
Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp
Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet
February 21, 09:40
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki
February 20, 09:17
Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million
Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador (Photo: Business Wire
February 19, 15:15
Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete
February 19, 11:00
Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
Novotech, a global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel ther
February 18, 15:20
Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of bo
Five-time Olympic Medalist and fashion icon, Gabby Thomas, is the latest ambassador to join Amazfit'
February 16, 09:30
Five-Time Olympic Medalist Gabby Thomas Joins Amazfit as Athlete Ambassador
Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), is proud to announce five-time Olympic Medalist and fashion icon, Gabby Thomas, as the latest ambassador to join the
February 14, 15:45
Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now a
*For research purposes only. Anticipated visual image of LiCellGrow. All features subject to change.
February 11, 11:30
PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work together on the development of primary T-cell(*1) expansion culture processes that will seek to accelerate the manufacturi
February 06, 09:35
Parse Biosciences Invalidates All 10x Genomics’ Patent Claims Asserted Against Its Products
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54199035&newsitemid=20250204152815&lan=en-US&anchor=Parse+Biosciences&index=1&md
February 04, 16:35
ELIQUENT Life Sciences Announces: Rob Wojciechowski Named Chief Operations Officer
ELIQUENT Life Sciences (ELIQUENT), a global regulatory, quality, and safety consulting firm, today announced the appointment of Rob Wojciechowski as Chief Operations Officer (COO). In this new role, R
GE HealthCare’s contrast media manufacturing site in Cork (Photo: Business Wire)
January 31, 17:24
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
GE HealthCare (Nasdaq: GEHC) today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on
January 31, 15:37
IMCAS 2025: New Galderma Phase IIIb Data Reinforce Rapid Onset and Long-lasting Aesthetic Improvement with RelabotulinumtoxinA (Relfydess™)
Galderma (SWX:GALD), the pure-play dermatology category leader, announced today results from its new phase IIIb RELAX clinical trial demonstrating the rapid onset and the long-lasting duration of aest
(Photo: Ferrer)
January 31, 14:25
Ferrer is Recognized for Its Best-in-class Ethics and Compliance Program
Ferrer has achieved Compliance Leader Verification™, the prestigious recognition granted by Ethisphere, which distinguishes the pharmaceutical company as a global leader in upholding ethical and respo
January 31, 13:12
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.takeda.com&esheet=54196039&newsitemid=20250129509380&lan=en-US&anchor=Takeda&index=1&md5=98fdda2da61995100aa6dbd136297ebe)
January 31, 09:30
Brandnew Clinic Celebrates 15th Anniversary with Exclusive Promotions and Events
Brandnew Clinic (www.brandnewclinic.com) has announced a month-long celebration in February to commemorate its 15th anniversary and express gratitude to its loyal clients. Under the leadership of Dr.
January 30, 15:50
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
Takeda (TOKYO:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54191699&newsitemid=20250127274764&lan=en-US&anc
January 30, 15:35
Galderma Demonstrates Injectable Aesthetics Leadership in Medication-Driven Weight Loss With New Research and First International Consensus-Based Guidelines
Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven weight loss on the skin and the importance of factoring in aesthetic treatment goal
January 30, 11:55
ImmunoMet Therapeutics Presents Updated Clinical Data from Phase 1b Study of Lixumistat in Pancreatic Cancer at ASCO-GI Meeting
ImmunoMet Therapeutics, Inc., (“ImmunoMet”, or the “Company”), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data update from t
January 24, 11:15
LTIMindtree Renews its Strategic Alliance with the Association of American Medical Colleges (AAMC)
LTIMindtree (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ltimindtree.com%2F&esheet=54183242&newsitemid=20250120318350&lan=en-US&anchor=LTIMindtree&index=1&md5=f780cd94b90cf27
January 23, 15:24
IMCAS 2025: Galderma’s Broad Presence and New Data on Recently Launched Products Restylane® SHAYPE™ and Relfydess® Reaffirm Its Category Leadership
Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 - February 1 in Paris, F
January 23, 11:10
Novotech Releases Comprehensive Report on Oncolytic Virus Therapy
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th
January 22, 14:35
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
Women’s cancer testing has declined globally, according to the latest Hologic Global Women’s Health Index (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwomenshealthindex.com&esheet
January 21, 11:30
Biocytogen and Acepodia Join Forces to Advance Bispecific Antibody and Dual-Payload ADCs for Treating Complex Tumors
Biocytogen (HKEX: 02315) and Acepodia (6976:TT), today announced a groundbreaking strategic partnership to jointly assess a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This co
Novotech Triple Negative Breast Cancer Clinical Trial Report
January 17, 14:30
Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Trip
January 17, 08:47
SINOVAC Issues Statement Regarding Privy Council Judgment
Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Judicial Committee of the Privy Council in London, E
January 15, 11:15
Mesmerise to collaborate with Mayo Clinic to Transform Medical Education and Healthcare Workforce Training
Mesmerise is proud to announce the creation of NeuRealities, Inc., a transformative company designed to revolutionize medical education and healthcare training. As part of a know-how agreement with Ma
January 14, 16:20
Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss
Galderma (SWX:GALD) announces positive first results from a trial designed to explore the benefits of Restylane® Lyft™ or Contour™ in combination with Sculptra® in patients with medication-driven weig
January 14, 16:10
Zepp Health to Showcase Groundbreaking Innovations at CES Pepcom & ShowStoppers Media Events
--CES -- Zepp Health Corporation (NYSE: ZEPP), a global leader in health technology and smart wearables, is thrilled to announce its participation in the CES Pepcom and ShowStoppers media events. Thes
January 12, 12:35
Biocytogen Announces Licensing of Fully Human Antibodies with SOTIO to Develop Novel ADC SOT109 for Colorectal Cancer Treatment
Biocytogen (HKEX: 02315) (https://en.biocytogen.com.cn/), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antib
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIM
January 10, 11:05
BOSTON ONCOLOGY ARABIA and SPIMACO Partner to Localize Advanced Oral Oncology Treatments in Saudi Arabia
In a landmark step towards advancing cancer care in the Middle East, BOSTON ONCOLOGY ARABIA and SPIMACO have signed a Memorandum of Understanding (MoU) to localize the production of advanced oral onco
January 08, 10:35
Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits
Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercode™ WT Mega Kit (https://cts.businesswire.com/ct/CT?id=sma
January 07, 10:09
Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today provided an update on recent business highlights and financial performance for 2024 and strategi
January 02, 09:03
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54169696&newsitemid=20241219442534&lan=en-US&anchor=%28TSE%3A4502%2FNY
December 24, 2024 10:35
BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference
BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54170287&newsitemid=20241223168194&lan=en-US&anchor=BeiGene&index=1&md5=7a7ba2e89608bb25a23fb84e5c3
December 24, 2024 10:30
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody/ADC therapeutics, announced that Adcendo ApS (“Adcendo”),
December 24, 2024 09:46
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa; Head Office: Minato-ku, Tokyo), a wholly-owned subsidiary of H.U. Group Holdings, Inc. (Chairman, President and Group CEO: Shigekazu Takeuchi;
Aster Guardians Global Nursing Award worth USD $250,000 (Photo: AETOSWire)
December 23, 2024 15:35
Aster Guardians Global Nursing Award 2025 Worth US$250,000 Now Open for Nominations Worldwide
Aster DM Healthcare has announced the fourth edition of the Aster Guardians Global Nursing Award, inviting nurses worldwide to apply for the prestigious USD 250,000 prize. The award recognizes excepti
December 23, 2024 14:45
SBC Medical Group Co., Ltd. Sells Two Subsidiaries
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as “SBCMG”), has de
December 20, 2024 09:50
ClinChoice Extends 13-Year Medidata Partnership with the Addition of Clinical Data Studio to Improve Data Management and Strengthen Clinical Trial Capabilities
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has renewed its long-standing enterprise partnership with ClinChoice (https://cts.bu
GC Aesthetics’ PERLE™ Breast Implant features a proprietary surface technology (BioQ™) and GCA’s ind
December 19, 2024 14:50
GC Aesthetics® Announces Decade-Long Clinical Evaluation of PERLE™ Breast Implants
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets, is proud to announce the initiation of a significant m
December 19, 2024 13:40
Novotech Releases Report on Global Parkinson’s Disease Clinical Trial Landscape
Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024 (https://cts.businesswir
December 19, 2024 10:30
Novotech Publishes Report on the Global COVID-19 Clinical Trial Landscape, Highlighting Key Trends, Therapeutic Advancements, and Challenges in Drug Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an i
(Photo: Business Wire)
December 18, 2024 15:50
Carestream Secures Crucial Business Partner Agreement in Algeria
Carestream Health recently secured an agreement with BSF Medical - SARL, a leading distributor of medical solutions covering cardiology, urology, endoscopy, radiology, and pharmaceutical products in A
December 18, 2024 14:30
Biocodex Strengthens Supply Chain Resilience with Kinaxis
Biocodex (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.biocodex.com%2Fen%2F&esheet=54166747&newsitemid=20241216873592&lan=en-US&anchor=Biocodex&index=1&md5=b3bef2f213ddbbd3737
December 18, 2024 13:40
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine
December 17, 2024 11:20
HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54166940&newsitemid=20241216604376&lan=en-US&anchor=HistoSonics&index=1&md5=035f1602d28e12cb40e
Clinical Trial Management Award for Novotech (Graphic: Business Wire)
December 17, 2024 09:35
Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel th
December 15, 2024 14:45
Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis
Galderma (SWX:GALD) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nemluvio® (nemolizumab) for the treatment of patients 12 years and older with moderate
December 15, 2024 13:40
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing
*For research purposes only. (Graphic: Business Wire)
December 15, 2024 13:15
PHC Live Cell Metabolic Analyzer (LiCellMo) Receives 2024 Innovation Award from The Analytical Scientist
The Biomedical Division of PHC Corporation (https://www.phchd.com/global/phc) (Headquarters: Chiyoda-ku, Tokyo, Japan; President: Nobuaki Nakamura), has received a 2024 Innovation Award from The Analy
December 13, 2024 15:37
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union
Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing aut
December 13, 2024 13:35
Tanner Pharma Expands Global Access to Botensilimab and Balstilimab Through Partnership With Agenus
Tanner Pharma, a global provider of specialty medicine access solutions, today announced a collaboration with Agenus, a leading immuno-oncology company, to provide expanded access to botensilimab (BOT
December 13, 2024 11:55
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine at ESMO-IO 2024
PDC*line Pharma, a clinical-stage biotech company developing a new class of immunotherapies for cancers, presented the primary results of its phase I/II clinical trial for PDC*lung01, an innovative of
December 13, 2024 11:45
Octapharma Injects Efficiency Into Its Supply Chain With Kinaxis
Octapharma (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.octapharma.ca%2Fen%2F&esheet=54164832&newsitemid=20241211594907&lan=en-US&anchor=Octapharma&index=1&md5=ca5c5d335e96ce
December 13, 2024 11:40
Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications
Parse Biosciences, a leader in scalable single cell sequencing solutions, today announced the expansion of its Evercode BCR (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parse
December 13, 2024 09:01
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54165415&newsitemid=20241211148492&lan=en-US&anchor=TSE%3A4502%2FNYSE%
December 12, 2024 15:00
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that plans to change its name to BeOne Medicines Ltd., today announced the presentation of new clinical data at the 66
Ultrastructural representation of the BK polyomavirus capsid, featuring 72 pentamers that form its d
December 12, 2024 14:55
Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
Orthogon Therapeutics, a developer of novel antiviral medicines, today announced the closing of an oversubscribed financing round, exceeding its $5M target and bringing total funding to over $25M. Thi
December 12, 2024 10:35
SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services
SK pharmteco, a global contract development, manufacturing, and analytical testing organization serving the pharmaceutical and cell & gene therapy industries, today announced the launch of a brand uni
December 11, 2024 09:55
Huonslab Announces Successful Enrollment and Administration of First Patient in Phase 1 Pivotal Study for Hydizyme™ (rHuPH20)
Huonslab (https://huonslab.com/layout/eng/home.php?go=main&), a subsidiary of Huons Global (https://huonsglobal.com/eng/home.php) (KOSDAQ: 084110), announced on December 10th the successful enrollment
December 06, 2024 11:20
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54161904&newsitemid=20241205693431&lan=en-US&anchor=Parse+Biosciences&index=1&md
Nurse Maria Victoria Juan from Philippines – Winner of Aster Guardians Global Nursing Award 2024 (Ph
December 05, 2024 13:50
Nurse Maria Victoria Juan From Philippines Wins the Prestigious Aster Guardians Global Nursing Award 2024
Nurse Maria Victoria Juan from Philippines, a Consultant at Philippines Army Health Services and Colonel, Reserve Force of the Armed Forces of the Philippines, has been announced as the winner of the
Charlene Dark, newly appointed chief operating officer of Avania. (Photo: Business Wire)
December 05, 2024 10:45
Avania Appoints Innovative Operations Strategist Charlene Dark as New Chief Operating Officer
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54160539&newsitemid=20241203677092&lan=en-US&anchor=Avania&index=1&md5=4b5f83247ba447bb7edd17
December 04, 2024 10:45
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54160718&newsitemid=20241202182459&lan=en-US&anchor=TSE%3A4502%2FNYSE%
Nihon Medi-Physics headquarters and woman looking at molecular imaging images (Photo: Business Wire)
December 02, 2024 14:15
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from Sumitomo Chemical (TYO: 4005) the 50% stake it does not already own. As part
November 29, 2024 09:23
Galderma’s Phase III OLYMPIA 1 Data Published in JAMA Dermatology Demonstrate That Nemolizumab Improves Core Signs and Symptoms of Prurigo Nodularis
Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with moderate-to-
Portrait of Dr. Martin Steinhart, CEO AOP Health (Photo: AOP Health/Studio Koekart)
November 28, 2024 10:15
U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting
AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna, Austria, announced that the U.S. Food and Drug Administration (FDA) has granted regulatory approval for Rapiblyk™ (landiolol) in the hosp
November 27, 2024 16:00
Viromed Medical AG: Cold Plasma as a Digital Antibiotic for the Lungs
Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65; “Viromed”) is pushing forward research into cold plasma for the prevention of ventilator-associated pneumonia (VAP). Under the scientific directio
November 24, 2024 11:10
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
Ribbon Cutting of the Lab (Photo: Business Wire)
November 22, 2024 16:40
Rigaku BioScience Lab Opens in USA
Rigaku Corporation, a Rigaku Holdings Group company that serves as a global solution partner for X-ray analytical equipment (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), opened Rigaku
November 22, 2024 10:50
Global Cell and Gene Therapy Trials: Driving Innovation in Oncology and Beyond
Novotech, the global full-service clinical Contract Research Organization (CRO), has published its latest whitepaper, offering in-depth analysis and emerging trends and advancements within the rapidly
November 22, 2024 09:55
The Future of Diffuse Large B-Cell Lymphoma (DLBCL) Treatment: Insights from Global Research
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, sh
November 21, 2024 11:40
Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
November 20, 2024 17:10
NationsBenefits Acquires Good Measures to Revolutionize Food as Medicine Solutions
NationsBenefits®, the leading fintech, benefits, and outcomes platform for healthcare, announced the acquisition of Good Measures, the leading platform for Food as Medicine supporting health plans and
November 20, 2024 15:30
Pharmanovia Signs Novel Biologic In-Licensing Agreement With Lindis Biotech to Commercialise Catumaxomab for Treatment of Rare Condition, Malignant Ascites
Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the expansion of its o
November 19, 2024 15:50
HistoSonics® Enrolls First Patients in Company’s Novel BOOMBOX Master Study
HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients were enrolled in their novel prospective master protocol study, called BOOMBOX, design
November 19, 2024 11:35
Novotech Releases Comprehensive Report on the Global Clinical Trial Landscape for Small Cell Lung Cancer (SCLC)
Novotech, the global full-service clinical Contract Research Organization (CRO), has published a new report, Small Cell Lung Cancer: Global Clinical Trial Landscape 2024 (https://cts.businesswire.com/
(Graphic: Business Wire)
November 17, 2024 15:40
BeiGene Unveils Proposed Name Change to BeOne Medicines, Reaffirming Its Mission to Unite Global Community Against Cancer
BeiGene, Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54152783&newsitemid=20241114671168&lan=en-US&anchor=BeiGene&index=1&md5=e4496ffaca181720a54a2
25 per page50 per page75 per page100 per page